Garde Capital, Inc. Gilead Sciences, Inc. Transaction History

Garde Capital, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 28, 2023	BUY	$76.01 - $86.7 $279,716 - $319,056	3,680 New	3,680 $284,000
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $504,617 - $565,303	-8,070 Closed	0 $0
Q2 2018 Aug 20, 2018	SELL	$64.88 - $75.68 $6,488 - $7,568	-100 Reduced 1.22%	8,070 $572,000
Q1 2018 May 16, 2018	SELL	$72.84 - $88.8 $11,654 - $14,208	-160 Reduced 1.92%	8,170 $616,000
Q3 2017 Nov 17, 2017	BUY	$72.11 - $85.47 $600,676 - $711,965	8,330	8,330 $675,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Garde Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Garde Capital, Inc. with notifications on news.